Lamictal Pay-For-Delay Case Not Best High Court Lure
The government has asked the U.S. Supreme Court not to review a Third Circuit decision in a pay-for-delay case against GlaxoSmithKline and Teva over the anticonvulsant Lamictal, and experts said the...To view the full article, register now.
Already a subscriber? Click here to view full article